Latest Breaking News On - National university of asunci - Page 5 : comparemela.com
2021/07/07 10:17 (Facebook, Medigen Vaccine Biologics Corp. photo) (Facebook, Medigen Vaccine Biologics Corp. photo) TAIPEI (Taiwan News) Medigen Vaccine Biologics Corp., the producer of one of Taiwan’s two home-grown COVID-19 vaccines, announced Tuesday (July 7) that it has officially applied to carry out Phase 3 clinical trials in Paraguay. The trials will take place at an affiliated hospital of the National University of Asunción in the capital of Paraguayan capital. The country is Taiwan’s only diplomatic ally in South America. Paraguay s National Health Surveillance Authority (DINAVISA) will determine whether to greenlight the application for clinical trials, which will compare the efficacy of the Medigen and AstraZeneca vaccines through immunobridging, reported CNA.
ParaguayTaipeiT-ai-peiTaiwanUnited-statesAmericaParaguayanAstrazenecaParaguay-national-health-surveillance-authorityFacebookDrug-administration